相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging of Vx-2 rabbit tumors with αvβ3-integrin-targeted 111In nanoparticles
Grace Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner
Chunfu Zhang et al.
CANCER RESEARCH (2007)
Early in vivo assessment of angiostatic therapy efficacy by molecular MRI
Willem J. M. Mulder et al.
FASEB JOURNAL (2007)
Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma
Mark A. Rosen et al.
CLINICAL CANCER RESEARCH (2007)
FDA drug approval summary: Bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer
Martin H. Cohen et al.
ONCOLOGIST (2007)
Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer
Coen I. M. Baeten et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
In vitro and in vivo characterization of 64Cu-labeled Abegrin™ a humanized monoclonal antibody against integrin αvβ3
Weibo Cai et al.
CANCER RESEARCH (2006)
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor:: Potential tumor imaging agents
Thomas D. Harris et al.
BIOCONJUGATE CHEMISTRY (2006)
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200
B. J. Giantonio et al.
ANNALS OF ONCOLOGY (2006)
Vaccines targeting tumour angiogenesis - a novel strategy for cancer immunotherapy
Y Okaji et al.
EJSO (2006)
Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors
YP Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Vascular integrins in tumor angiogenesis:: Mediators and therapeutic targets
Gian Carlo Alghisi et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: Implications for enhanced local drug delivery
KC Crowder et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2005)
Molecular MR imaging of melanoma angiogenesis with ανβ3-targeted paramagnetic nanoparticles
AH Schmieder et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates
R Shukla et al.
CHEMICAL COMMUNICATIONS (2005)
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells
P Hölig et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
A novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody coated 90Y-labeled nanoparticles
LY Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
90Y and 111In complexes of a DOTA-conjugated integrin αvβ3 receptor antagonist:: Different but biologically equivalent
DC Onthank et al.
BIOCONJUGATE CHEMISTRY (2004)
Nonpeptide αvβ3 antagonists.: Part 11:: Discovery and preclinical evaluation of potent αvβ3 antagonists for the prevention and treatment of osteoporosis
PJ Coleman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting αvβ3 integrins in tumor angiogenesis
P McQuade et al.
BIOCONJUGATE CHEMISTRY (2004)
Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model
Y Imagawa et al.
AURIS NASUS LARYNX (2004)
Detection of injury-induced vascular remodeling by targeting activated αvβ3 integrin in vivo
MM Sadeghi et al.
CIRCULATION (2004)
MRI monitoring of avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer
A Preda et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction
DF Meoli et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors
HT Tran et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
MicroPET and autoradiographic imaging of breast cancer alpha(v)-integrin expression using F-18- and Cu-64-labeled RGD peptide
XY Chen et al.
BIOCONJUGATE CHEMISTRY (2004)
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature:: A novel mechanism for IL-21
C Jackaman et al.
JOURNAL OF IMMUNOLOGY (2003)
Design, synthesis, and evaluation of radiolabeled integrin αvβ3 receptor antagonists for tumor imaging and radiotherapy
TD Harris et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2003)
MRI monitoring of tumor response following anglogenesis inhibition in an experimental human breast cancer model
K Turetschek et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Human CD4(+) T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma
SD Hess et al.
JOURNAL OF IMMUNOLOGY (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis
GM Lanza et al.
CIRCULATION (2002)
Utility (or not) of Gd-DTPA-based dynamic MRI for breast cancer diagnosis and grading
TPL Roberts et al.
ACADEMIC RADIOLOGY (2002)
Enhanced pathological angiogenesis in mice lacking beta(3) integrin or beta(3) and beta(5) integrins
LE Reynolds et al.
NATURE MEDICINE (2002)
Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques
S Flacke et al.
CIRCULATION (2001)
A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti αvβ3) antibody in patients with metastatic cancer
JA Posey et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging
R Weissleder et al.
BIOCONJUGATE CHEMISTRY (2001)
The activation state of αvβ3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin
O Helluin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: Effects of VEGF-toxin conjugate on tumor microvessel density
R Wild et al.
MICROVASCULAR RESEARCH (2000)
Tumor angiogenesis factors reduce leukocyte adhesion in vivo
SC Tromp et al.
INTERNATIONAL IMMUNOLOGY (2000)
Structure and function of the methionine aminopeptidases
WT Lowther et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
分享论文
